Stock Events

Stock Events

Mersana Therapeutics (MRSN) Q3 2024 Earnings

13AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.36

-0.29

-0.23

-0.16

Details

Expected EPS

-0.166751

Actual EPS

-0.2

Surprise EPS

-0.03

Surprise Percent

+19.94%

Description

Mersana Therapeutics (MRSN) has reported earnings of -0.2 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.